#: 45-0031-82), rat -mCD4 Pacific Blue (Clone: RM 4C5; BD; Cat

#: 45-0031-82), rat -mCD4 Pacific Blue (Clone: RM 4C5; BD; Cat.# 558107), rat -mCD8 R-phycoerythrin (PE)-Cy7 (Clone: 53C6.7; eBiosience; Cat#:25-0081-82), Live/Dead Fixable Aqua Dead Cell Stain kit (0.5l) (Invitrogen; Cat.#:”type”:”entrez-nucleotide”,”attrs”:”text”:”L34957″,”term_id”:”522200″,”term_text”:”L34957″L34957) in the presence of Fc Block (0.83l) [rat -mCD16/CD32] (Clone: 2.4G2; BD; Cat.#: 553142) and IgG antibodies from mouse serum 3-Methoxytyramine (MilliPORE SigMGA; Cat.#: I8765) overnight (16h) at 4C. and CPXV14 was subjected to PCR analysis using primer pair L-152-F (5-AGAAGCTGTACGAGCATAGTAACTTTTTATCAGACG-3) and R-188-R (5-ACAATCATGTGGACCGGATAAACCACGA-3). The DNA fragments were predicted to contain 941 base pairs (bp) and 2,536 bp for wild-type CPXV and CPXV14, respectively. C) Next generation sequencing analysis of CPXV14. Genomic DNA isolated from CPXV14 was sequenced on a MiSeq sequencer (Illumina). The resulting DNA reads were aligned to the published genome sequence of CPXV-BR (GenBank accession # “type”:”entrez-nucleotide”,”attrs”:”text”:”NC_003663″,”term_id”:”30844336″,”term_text”:”NC_003663″NC_003663) using Geneious v8.1.4 software. Sequences were identical outside the CPXV14 ORF.(DOCX) ppat.1010783.s002.docx (466K) GUID:?C28178CF-BDCD-44BF-B0AD-4DE125CD4007 S3 Fig: CPXV14 3-Methoxytyramine is a late gene that is non-essential for growth but are expected to contribute to the broad host range, virulence and immune evasion characteristics of CPXV. For instance, unlike VACV, CPXV encodes proteins that interfere with T cell stimulation, either directly or by preventing antigen presentation Rabbit polyclonal to ANGPTL3 or co-stimulation. When studying the priming of na?ve T cells, we discovered that CPXV, but not VACV, encodes a secreted factor that interferes with activation and proliferation of na? ve CD8+ and CD4+ T cells, respectively, in response to anti-CD3 antibodies, but not to other stimuli. Deletion mapping revealed that the inhibitory protein is encoded by CPXV14, a small secreted glycoprotein belonging to the poxvirus immune evasion (PIE) family and 3-Methoxytyramine containing a smallpoxvirus encoded chemokine receptor (SECRET) domain that mediates binding to chemokines. We demonstrate that CPXV14 inhibition of antibody-mediated T cell activation depends on the presence of Fc-gamma receptors (FcRs) on bystander cells. [9]. CD4+ T cells are not affected by these inhibitors of antigen presentation. Instead, their stimulation is directly inhibited by CPXV219, a B22 family protein [19]. The related protein MPXV197 in MPXV additionally inhibits CD8+ T cells and MPXV lacking MPXV197 is highly attenuated [19]. In addition, CPXV encodes soluble proteins that interfere with co-stimulation of T cells or activation of NK cells [7,20]. Here, we describe a novel function for the small secreted protein CPXV14 and its role in virulence and immune evasion. CPXV14 is a member of a superfamily of OPXV proteins which share the conserved structural poxviral immune evasion (PIE) domain [21]. Furthermore, CPXV14 is one of five CPXV proteins containing the smallpox encoded chemokine receptor (SECRET) domain which enables members of this protein family to bind and sequester a wide range of mouse and human CC and CXC chemokines [22,23]. We demonstrate that CPXV14 prevents activation and proliferation of na?ve T cells in response to anti-CD3 antibodies. Since deletion of CPXV14 from the CPXV genome restored T cell activation it seems that this function is unique among CPXV-encoded SECRET-domain proteins. Further investigation revealed that CPXV14 interference with antibody-mediated T cell activation required the presence of Fc-gamma receptors (FcR) on bystander cells. Moreover, CPXV14 directly bound to FcRs and interfered with the antibody-mediated activation of FcRs homologous recombination (S2C Fig). CPXV14 is expressed with late kinetics and deletion of CPXV14 did not affect viral growth in vitro (S3 Fig). When CPXV14-infected cells were added to -CD3/-CD28-stimulated splenocytes, we no longer observed a reduction of stimulation as observed for wildtype CPXV. Instead, CD4+ and CD8+ T cell stimulation was unaffected by CPXV14-infected cells similar to VACV (Fig 2D). These observations suggested that CPXV14 was necessary for the observed inhibition of T cell activation. CPXV14 comprises 202 amino acids (AA) including a predicted 23 AA signal sequence and, upon cleavage, a predicted molecular weight (MW) of 22.5 kDa (Fig 3A). In addition, CPXV14 contains five predicted N-linked glycosylation sites. (Fig 3A). To determine whether purified CPXV14 would block T cell activation, we isolated a His-tagged version of CPXV14 from transfected HEK293F cells. The purified protein is highly glycosylated as shown by PNGase F treatment (Fig 3C). When increasing concentrations of 3-Methoxytyramine purified CPXV14 were added to splenocytes in -CD3/-CD28 coated plates we observed that CD8+ T cell stimulation was reduced with a half-maximal concentration of 90pM (Fig 3D. Thus, CPXV14 is both necessary and sufficient for the observed inhibition of T cell stimulation by CPXV. Open in a separate window Fig 3 Poxviral SECRET-domain proteins inhibit T cell activation by plate-bound anti-CD3 and anti-CD28 antibodies.A) Alignment of CPXV14 with SECRET-domain containing protein-2 (ECTV008) of ectromelia virus (ECTV). Proteins were aligned using CLUSTAL O v1.2.1. The predicted signal sequence is.